Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Parasitol ; 184: 1-10, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29162347

ABSTRACT

Trypanosoma cruzi, the etiologic agent of Chagas disease, has to cope with reactive oxygen and nitrogen species during its life cycle in order to ensure its survival and infection. The parasite detoxifies these species through a series of pathways centered on trypanothione that depend on glutathione or low molecular mass dithiol proteins such as tryparedoxins. These proteins transfer reducing equivalents to peroxidases, including mitochondrial and cytosolic peroxiredoxins, TcMPx and TcCPx, respectively. In T. cruzi two tryparedoxins have been identified, TXNI and TXNII with different intracellular locations. TXNI is a cytosolic protein while TXNII due to a C-terminal hydrophobic tail is anchored in the outer membrane of the mitochondrion, endoplasmic reticulum and glycosomes. TXNs have been suggested to be involved in a majority of biological processes ranging from redox mechanisms to protein translation. Herein, a comparison of the TXNII interactomes under physiological and oxidative stress conditions was examined. Under physiological conditions, apart from the proteins with unknown biological process annotation, the majority of the identified proteins are related to cell redox homeostasis and biosynthetic processes, while under oxidative stress conditions, are involved in stress response, cell redox homeostasis, arginine biosynthesis and microtubule based process. Interestingly, although TXNII interacts with both peroxiredoxins under physiological conditions, upon oxidative stress, TcMPx interaction prevails. The relevance of the interactions is discussed opening a new perspective of TXNII functions.


Subject(s)
Oxidative Stress/physiology , Peroxiredoxins/metabolism , Thioredoxins/metabolism , Trypanosoma cruzi/chemistry , Trypanosoma cruzi/physiology , Cell Membrane/metabolism , Cytosol/enzymology , Electrophoresis, Gel, Two-Dimensional , Electrophoresis, Polyacrylamide Gel , Fluorescent Antibody Technique, Indirect , Hydrogen Peroxide/pharmacology , Mitochondria/enzymology , Mitochondrial Membranes/metabolism , Permeability , Peroxidases/metabolism , Protozoan Proteins/metabolism , Transfection , Trypanosoma cruzi/enzymology
2.
Biochim Biophys Acta ; 1864(1): 1-10, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26527457

ABSTRACT

Trypanosoma cruzi depends on the effectiveness of redox metabolism to survive and ensure infection in the host. Homeostasis of redox metabolism in T. cruzi is achieved by the actions of several proteins that differ in many aspects from host proteins. Although extensive research has been performed examining hydroperoxide cytosolic antioxidant defense centered on trypanothione, the mechanisms of mitochondrial antioxidant defense are not yet known. The aim of this study was to elucidate the partners of TcMPx antioxidant pathway and to determine the influence of the cellular context (physiological versus oxidative stress). Through co-precipitation coupled with a mass spectrometry approach, a variety of proteins were detected under physiological and oxidative stress conditions. Interestingly, functional category analysis of the proteins identified under physiological conditions showed that they were involved in the stress response, oxidoreduction, thiol transfer, and metabolic processes; this profile is distinct under oxidative stress conditions likely due to structural alterations. Our findings help to elucidate the reactions involving TcMPx and most importantly also reveal that this protein is present throughout the cell and that its interaction partners change following oxidative stress exposure. The involvement and significance of the proteins found to interact with TcMPx and other possible functions for this protein are discussed widening our knowledge regarding T. cruzi mitochondrial antioxidant defenses.


Subject(s)
Mitochondria/enzymology , Mitochondrial Proteins/metabolism , Peroxidases/metabolism , Protozoan Proteins/metabolism , Trypanosoma cruzi/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Chromatography, Liquid , Electrophoresis, Gel, Two-Dimensional , Hydrogen Peroxide/pharmacology , Microscopy, Confocal , Mitochondrial Proteins/genetics , Oxidants/pharmacology , Peroxidases/genetics , Protein Binding/drug effects , Protein Interaction Maps , Proteome/genetics , Proteome/metabolism , Proteomics/methods , Protozoan Proteins/genetics , Tandem Mass Spectrometry , Trypanosoma cruzi/enzymology , Trypanosoma cruzi/genetics
3.
Mycopathologia ; 159(4): 487-93, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15983733

ABSTRACT

Until recently, accurate microbiological diagnosis of invasive aspergillosis (IA) was seldom established in HSCT recipients. Blood samples are rarely positive for Aspergillus species, the reliability of the cultures depends of the specimen (if taken from a normally sterile site or not) and biopsy samples require invasive procedures, rarely recommended in patients with severe thrombocytopenia. Implementing the international consensus defining the microbiological criteria for the diagnosis of Aspergillus infection, we retrospectively evaluated the role of serum galactomannan (GM) detection by EIA to diagnose IA among HSCT patients with proven invasive fungal infection (IFI) and the impact of serum storage in GM concentrations. The EIA assay allowed categorizing as "probable" 5 of the 10 cases of "possible" aspergillosis (50%). Considering a lower cut-off level for the reaction (1.0), 80% of the cases could be categorized as "probable" aspergillosis. Positive or undetermined results were detected one to 4 months before the diagnosis of IA in eight of the 11 patients (72.7%) with proven IFI. Retesting the stored samples after a second storage for four years, we could observe lower reactivity in 20% of the samples. The detection of galactomannan by the EIA test represents a major advance in the diagnosis of IA in HSCT recipients at high risk of IA. A better understanding of the kinetics of the GM in different clinical situations is necessary to maximize the benefit of the test in Aspergillus surveillance.


Subject(s)
Aspergillosis/blood , Aspergillus/growth & development , Hematopoietic Stem Cell Transplantation/adverse effects , Mannans/blood , Adolescent , Adult , Aspergillosis/diagnosis , Aspergillosis/microbiology , Child , Female , Galactose/analogs & derivatives , Humans , Immunoenzyme Techniques , Male , Retrospective Studies , Specimen Handling
4.
Int J Vitam Nutr Res ; 68(3): 181-8, 1998.
Article in English | MEDLINE | ID: mdl-9637949

ABSTRACT

The effect of ascorbic acid (AA) on hepatic delta-aminolevulinic acid dehydratase (ALA-D) activity was studied. AA decreased enzyme activity by reducing maximum velocity and tended to increase the Michaelis constant. ALA-D inactivation by AA occurred similarly both in air and argonium atmosphere incubation. DTT reduced considerably the inhibitory effect of AA on ALA-D, but glutathione was ineffective in reversing inactivation. These data indicate that inhibition occurs mainly due to an acceleration of the oxidation rate mediated by the hepatic supernatant utilizing AA in sulfhydryl groups of cysteine residues present at the ALA-D active site. AA probably acts on cysteine from the ALA-D B site since cucumber and radish leaves ALA-D was not inhibited by AA (up to 16 mM). The addition of free radical scavengers to the medium did not alter ALA-D inactivation caused by AA, indicating that active oxygen species formed during AA oxidation were not directly related to -SH oxidation. The chelation of zinc ions from the enzyme by EDTA turned ALA-D more susceptible to the inhibitory effect of AA. This effect seems to involve mainly ZnB, which is known to bind to four cysteines. The present data suggest that AA may participate in the regulation of the heme biosynthesis pathway by promoting a reversible inactivation of ALA-D.


Subject(s)
Ascorbic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Liver/enzymology , Porphobilinogen Synthase/antagonists & inhibitors , Animals , Binding Sites , Cysteine/chemistry , Dithiothreitol/pharmacology , Edetic Acid/pharmacology , Free Radical Scavengers/pharmacology , Glutathione/pharmacology , Histidine/chemistry , Mannitol/pharmacology , NAD/pharmacology , Oxidation-Reduction , Porphobilinogen Synthase/chemistry , Rats , Sulfhydryl Compounds/chemistry , Superoxide Dismutase/pharmacology
5.
Rev Inst Med Trop Sao Paulo ; 39(3): 141-4, 1997.
Article in English | MEDLINE | ID: mdl-9460253

ABSTRACT

The present study concern on mycologic and immunochemical data obtained from two samples of a fungus considered as belonging to the species Paracoccidioides cerebriformis described by Moore in 1935, and maintained since then on Sabouraud's agar in the mycology collection of the Instituto de Medicina Tropical de São Paulo. After 60 years, the samples exhibited the same characteristics described by MOORE (1935). However, experimental lesions did not resulted in guinea-pigs inoculated intratesticularly. The dominant antigen in Paracoccidioides brasiliensis, 43 kDa glicoprotein (gp43), could not be demonstrated by SDS PAGE and Western blotting. Immunoelectrophoresis did not demonstrated the E arch of cathodic migration using a policlonal anti gp43 serum. According to these findings, it is concluded that the fungus described by MOORE (1935) as P. cerebriformis does not belong to the genus Paracoccidioides. Paracoccidioidomycosis should therefore be considered as resulting from infection by a single species, Paracoccidioides brasiliensis (Splendore, 1912) as asserted by ALMEIDA (1930). Further studies, through molecular biology methods, could identify the mentioned fungus.


Subject(s)
Paracoccidioides/classification , Paracoccidioides/immunology , Animals , Guinea Pigs , Humans , Immunohistochemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...